Soluble ICK-proteins could competitively interfere with the interactions of their corresponding receptors/ligands in the membrane of immune/tumor cells, which could subsequently alter the anti-tumor immunity and cancer outcomes (12, 15). The gene discussed is CILK1; the disease is cancer.